UK Markets closed

Bionano Genomics, Inc. (BNGO)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.6150+0.2350 (+6.95%)
As of 12:53PM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 2.24
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 36.2800
52-week low 31.1600
50-day moving average 31.7498
200-day moving average 32.4916

Share statistics

Avg vol (3-month) 37.6M
Avg vol (10-day) 316.89M
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 8284.1M
% held by insiders 11.92%
% held by institutions 125.84%
Shares short (14 Jul 2022) 444.17M
Short ratio (14 Jul 2022) 47.55
Short % of float (14 Jul 2022) 415.26%
Short % of shares outstanding (14 Jul 2022) 415.25%
Shares short (prior month 14 Jun 2022) 438.05M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 0.00%
Operating margin (ttm)-460.19%

Management effectiveness

Return on assets (ttm)-16.09%
Return on equity (ttm)-27.43%

Income statement

Revenue (ttm)20.51M
Revenue per share (ttm)0.07
Quarterly revenue growth (yoy)79.80%
Gross profit (ttm)3.87M
EBITDA -89.27M
Net income avi to common (ttm)-92.44M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)216.47M
Total cash per share (mrq)0.75
Total debt (mrq)11.12M
Total debt/equity (mrq)3.57
Current ratio (mrq)12.99
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-90.52M
Levered free cash flow (ttm)-50.28M